Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance.

PURPOSE Advances in computed tomography (CT) scanning have led to the detection of unsuspected pulmonary emboli (PE) on routine cancer staging scans. We hypothesized that these patients had signs or symptoms suggestive of PE that may have been overlooked by their health care providers. PATIENTS AND METHODS A retrospective chart review was performed on 59 patients found on routine cancer staging CT scans to have unsuspected PE. Information on patient demographics, malignancy characteristics, risk factors for venous thromboembolism (VTE), and symptoms was recorded. A retrospective case-control analysis was then performed using two age- and stage-matched control patients for each patient who had similar staging CT scans performed during the same period. RESULTS Fifty-two patients with unsuspected PE were identified. Forty-four percent had signs or symptoms commonly associated with PE; when fatigue was included, 75% were symptomatic. Ninety-two control patients were identified for 46 of the case patients. Patients with unsuspected PE were significantly more likely to have had a prior history of VTE (20% v 3%; P = .007). The patients with PE were significantly more likely than control patients to complain of fatigue (54% v 20%; P = .0002) and shortness of breath (22% v 8%; P = .02). There was no difference between the groups in administration of chemotherapy within 30 days, central venous catheter use, or erythropoietin therapy. CONCLUSION Seventy-five percent of patients found to have unsuspected PE on cancer staging CT scans were symptomatic. Fatigue and shortness of breath were significantly more common in patients with unsuspected PE than in control patients.

[1]  F. Parazzini,et al.  A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project , 2006, Annals of surgery.

[2]  A. Khorana,et al.  Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study , 2005, Cancer.

[3]  A. Encke,et al.  Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients , 2005, Thrombosis and Haemostasis.

[4]  L. Goodman,et al.  Small pulmonary emboli: what do we know? , 2005, Radiology.

[5]  Clifford W Colwell,et al.  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[6]  M. Prins,et al.  Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. , 2004, Archives of internal medicine.

[7]  C. McCollum,et al.  Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey , 2003, BMJ : British Medical Journal.

[8]  H. Liebman,et al.  Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment , 2003, American journal of hematology.

[9]  P. Boiselle,et al.  Multi-detector row spiral CT pulmonary angiography: comparison with single-detector row spiral CT. , 2001, Radiology.

[10]  G D Rubin,et al.  Unsuspected pulmonary embolism: prospective detection on routine helical CT scans. , 1998, Radiology.

[11]  G. Hommel,et al.  Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Paolo Prandoni,et al.  The Long-Term Clinical Course of Acute Deep Venous Thrombosis , 1996, Annals of Internal Medicine.

[13]  J. W. Henry,et al.  Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. , 1995, Chest.

[14]  T. Kjellstrom,et al.  Deep venous thrombosis and occult malignancy: an epidemiological study , 1994, BMJ.

[15]  E. Svendsen,et al.  Comparison of clinical and postmortem diagnosis of pulmonary embolism. , 1989, Journal of clinical pathology.

[16]  J. Hirsh,et al.  The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. , 1988, The New England journal of medicine.

[17]  A. Sebastian,et al.  Clinically unsuspected pulmonary embolism—an important secondary finding in oncology CT , 2006 .

[18]  L. Bonomo,et al.  Incidental detection of pulmonary emboli on routine MDCT of the chest. , 2005, AJR. American journal of roentgenology.

[19]  W. Hancock,et al.  Antimetastatic Agents. I. Role of Cellular Procoagulants in the Pathogenesis of Fibrin Deposition in Cancer and the Use of Anticoagulants and/or Antiplatelet Drugs in Cancer Treatment , 1988, Seminars in thrombosis and hemostasis.